Takeda Named Global Top Employer for Third Year Running

January 30, 2020

Osaka, Japan, January 30, 2020 --- Takeda Pharmaceutical Company Limited [TSE: 4502 / NYSE: TAK], (“Takeda”) today announced it has become part of a select group to receive global Top Employer® status for 2020. This is the third year in a row Takeda has been recognized with this prestigious honor. Established over 25 years ago, award certification is given annually by the Top Employers Institute to companies with outstanding employee offerings.

“Being named global Top Employer for three consecutive years is a testimony to our aspiration to create an exceptional people experience in every country where we operate,” said Padma Thiruvengadam, Takeda’s Chief Human Resources Officer. “It is important that every colleague at Takeda can fulfill their potential while helping to create a brighter future for millions of patients worldwide.”

The Top Employers Institute assesses 600 “People Development” practices of companies across 10 areas:

・Talent Strategy

・Performance Management

・Workforce Planning

・Leadership Development

・Talent Acquisition

・Career & Succession Management

・On-boarding

・Compensation & Benefits

・Learning & Development

・Culture


Top Employers Institute CEO David Plink commented, “The dedication that Takeda has demonstrated in creating a better world of work for their employees is inspiring and is reflected in the company being recognized as a global Top Employer for three years running. Takeda has consistently implemented their people practices on a global scale because they truly believe that their employees sit at the heart of what they do, and this really set them apart as a Top Employer. Congratulations!”

Takeda surpassed the requirements of the Top Employers Institute, with particular distinction in the areas of Talent Strategy, Career & Succession Management and Performance Management, receiving accreditation in more than 30 countries and regions, across four geographic areas:

  • Asia Pacific: Australia, China, Hong Kong, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan and Thailand
  • Europe: Austria, Denmark, Finland, Ireland, Kazakhstan, Portugal, Russia, Spain, Turkey and Ukraine
  • Latin America: Argentina, Brazil, Colombia, Ecuador, Mexico and Peru
  • Middle East: Egypt, Israel, Saudi Arabia and United Arab Emirates
  • South Africa
  • United States

To learn more about the Top Employers Institute and the Top Employers certification please visit: www.top-employers.com.

About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.
For more information, visit https://www.takeda.com.

Media contacts

Katie Joyce
katie.joyce@takeda.com
+1 781 482 2779

Vince Docherty
vince.docherty@takeda.com
+65 8332 4233

Wendy Chung
wendy.chung@takeda.com
+65 8321 5611